Loss of CBX7 expression has been described in several malignant neoplasias, including human colon and thyroid carcinomas proposing CBX7 as a tumor suppressor gene with a key role in cancer progression. This role is supported from the development of benign and malignant neoplasias in Cbx7 null mice. The aim of our work has been to investigate the mechanisms underlying the CBX7 oncosuppressor activity by analyzing the microRNAs (miRNAs) regulated by CBX7.
miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene / Forzati, Floriana; De Martino, Marco; Esposito, Francesco; Sepe, Romina; Pellecchia, Simona; Malapelle, Umberto; Pellino, Gianluca; Arra, Claudio; Fusco, Alfredo. - In: BMC CANCER. - ISSN 1471-2407. - 17:1(2017), p. 170. [10.1186/s12885-017-3158-z]
miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene
Forzati, Floriana;De Martino, Marco;Sepe, Romina;Pellecchia, Simona;Malapelle, Umberto;Pellino, Gianluca;Arra, Claudio;Fusco, Alfredo
2017
Abstract
Loss of CBX7 expression has been described in several malignant neoplasias, including human colon and thyroid carcinomas proposing CBX7 as a tumor suppressor gene with a key role in cancer progression. This role is supported from the development of benign and malignant neoplasias in Cbx7 null mice. The aim of our work has been to investigate the mechanisms underlying the CBX7 oncosuppressor activity by analyzing the microRNAs (miRNAs) regulated by CBX7.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
